Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Ann Emerg Med ; 39(4): 359-65, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11919521

RESUMEN

STUDY OBJECTIVE: Controversy surrounds the use of buffers during cardiac arrest to correct acidosis. The objective of this study was to determine whether attenuation or neutralization of cerebral acidosis by Carbicarb alters hippocampal glutamate levels, neuronal cell death, and neurologic deficits after reperfusion from asphyxial cardiac arrest in rats. METHODS: Rats were prospectively randomized to either a control (n=45), low-dose Carbicarb (LDC; 3 mL/kg, n=45), or high-dose Carbicarb (HDC; 6 mL/kg, n=45) group in a blinded fashion during resuscitation after 8 minutes of asphyxial cardiac arrest. Microdialysis was used to assess brain pH and glutamate. A neurologic deficit score and neuronal cell death in the hippocampus were determined at day 7. RESULTS: Resuscitation was greatest in LDC rats (42/45) and least in HDC rats (28/45) versus that in control rats (34/45). Brain pH was higher in the LDC and HDC rats 10 minutes after resuscitation and remained higher than that of control rats for 120 minutes after resuscitation. Glutamate levels at 10 to 120 minutes after reperfusion were lowest in the LDC rats. LDC rats had the lowest neurologic deficit score (1+/-2) versus that of control rats (13+/-8) and HDC rats (19+/-6). Hippocampal neuronal cell death was lowest in LDC rats (30+/-20) versus that in control rats (86+/-47) and HDC rats (233+/-85). CONCLUSION: LDC administered during resuscitation from asphyxial cardiac arrest attenuated acidosis, improved resuscitation, and reduced neurologic deficits and the number of dead hippocampal neurons. Neutralization of cerebral acidosis with HDC increased the number of dead hippocampal neurons and neurologic deficits after resuscitation from cardiac arrest in rats.


Asunto(s)
Asfixia/complicaciones , Isquemia Encefálica/tratamiento farmacológico , Carbonatos/uso terapéutico , Paro Cardíaco/complicaciones , Daño por Reperfusión/tratamiento farmacológico , Bicarbonato de Sodio/uso terapéutico , Acidosis/tratamiento farmacológico , Acidosis/etiología , Animales , Encéfalo/metabolismo , Isquemia Encefálica/etiología , Isquemia Encefálica/metabolismo , Muerte Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Combinación de Medicamentos , Ácido Glutámico/efectos de los fármacos , Ácido Glutámico/metabolismo , Hipocampo/metabolismo , Neuronas/efectos de los fármacos , Ratas , Recuperación de la Función/efectos de los fármacos , Daño por Reperfusión/etiología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA